Product Recalls in Vermont

Product recalls affecting Vermont — including food, drugs, consumer products, medical devices, and vehicles distributed to Vermont. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,497 recalls have been distributed to Vermont in the last 12 months.

47,027 total recalls
2,497 in last 12 months

Showing 1038110400 of 13,356 recalls

DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lansoprazole Delayed-Release Capsules Recalled by Wockhardt Usa Inc. Due to...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Zolpidem Tartrate Tablets Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Captopril Tablets Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lansoprazole Delayed-Release Capsules Recalled by Wockhardt Usa Inc. Due to...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Zonisamide Capsules Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Amlodipine Besylate Tablets Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Zonisamide Capsules Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Captopril Tablets Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Metoprolol Succinate Extended-Release Tablets Recalled by Wockhardt Usa Inc....

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Famotodine Tablets Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Famotodine Tablets Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Famotodine Tablets Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Clarithromycin Tablets Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Famotodine Tablets Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Metoprolol Succinate Extended-Release Tablets Recalled by Wockhardt Usa Inc....

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Zolpidem Tartrate Tablets Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lisinopril Tablets USP Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Amlodipine Besylate Tablets Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lisinopril Tablets USP Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Amlodipine Besylate Tablets Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund